These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Tacrine in Alzheimer's disease. Levy R Lancet; 1989 Aug; 2(8658):329. PubMed ID: 2569126 [No Abstract] [Full Text] [Related]
5. [Tacrine against Alzheimer disease? Still uncertain for which patients may the treatment be beneficial]. Wallin A Lakartidningen; 1996 Jan; 93(1-2):22-4. PubMed ID: 8544526 [No Abstract] [Full Text] [Related]
6. Alzheimer's disease and THA: a review of the cholinergic theory and of preliminary results. Boller F; Forette F Biomed Pharmacother; 1989; 43(7):487-91. PubMed ID: 2684292 [TBL] [Abstract][Full Text] [Related]
7. [Tacrine]. Dávila C; Viteri C; de Castro P Rev Med Univ Navarra; 1997; 41(1):58-64. PubMed ID: 9527715 [TBL] [Abstract][Full Text] [Related]
8. Galantamine: new preparation. The fourth cholinesterase inhibitor for Alzheimer's disease. Prescrire Int; 2001 Dec; 10(56):180-1. PubMed ID: 11824442 [TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease: the role of tacrine therapy. Jogerst G Iowa Med; 1995 Oct; 85(10):409-11. PubMed ID: 7591656 [No Abstract] [Full Text] [Related]
15. Pharmacoepidemiology of tacrine in Alzheimer's disease. Begaud B; Haramburu F; Miremont G Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():77-8. PubMed ID: 8899701 [No Abstract] [Full Text] [Related]
16. Effects of tetrahydroaminoacridine (tacrine) derivatives and physostigmine in convulsions induced by pentylenetetrazol. Herink J; Koupilová M; Hrdina V Act Nerv Super (Praha); 1989 Dec; 31(4):303-5. PubMed ID: 2638124 [No Abstract] [Full Text] [Related]
17. [Tacrine and "profitability"]. Nygaard HA Tidsskr Nor Laegeforen; 1997 Feb; 117(5):726. PubMed ID: 9102968 [No Abstract] [Full Text] [Related]
18. Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease. Prescrire Int; 2003 Dec; 12(68):230-1. PubMed ID: 14986699 [TBL] [Abstract][Full Text] [Related]
19. Treatment of Alzheimer's disease with short- and long-term oral THA and lecithin: a double-blind study. Fitten LJ; Perryman KM; Gross PL; Fine H; Cummins J; Marshall C Am J Psychiatry; 1990 Feb; 147(2):239-42. PubMed ID: 2405720 [TBL] [Abstract][Full Text] [Related]